This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 50 mg capsules. The contract has a ceiling value of $2,675.40 and a completion date of May 13, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4567721242 VYVANSE 60 MG CAPSULE 100S. The contract has a total ceiling value of $8,535.33 and runs through March 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vyvanse 20 mg capsules. The contract has a ceiling value of $2,476.14 and runs through December 16, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,358.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567410765 VYVANSE 30 MG CAPSULE 100S and has a completion date of February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.59 firm fixed-price contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The award has a ceiling value of $1,673.36 and a completion date of September 10, 2024. The contract is a Firm Fixed Price type. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,675.40 firm fixed-price contract is for the supply of 100 units of the medication VYVANSE 30 MG CAPSULE. The contract has a completion date of January 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 50 mg capsules. The contract has a ceiling value of $1,258.30 and a period of performance through May 9, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.75, is for the supply of VYVANSE 40 MG CAPSULE 100S, a medication. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a for-profit organization and a registered vendor in the System for Award Management...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563696090 - VYVANSE 30 MG CAPSULE 100S. The contract has a ceiling value of $4,998.54 and runs through February 20, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...